Hypoplastic right heart syndrome, thrombosis, Tricuspid atresia.
Conditions
Interventions
Thirty patients undergoing the total cavopulmonary shunt will be divided into two groups: 15 patients will receive oral anticoagulant (warfarin sodium) in group 1 from the first day after surgery, th
drug
D03.438.150.446.520.914
Sponsors
Hospital do Coração da Associação do Sanatório Sirio
Hospital do Coração da Associação do Sanatório Sirio
Eligibility
Inclusion criteria
Inclusion criteria: Scheduling total cavopulmonary operation according to the clinical criteria for surgery. Parents or guardians agree to the inclusion in the study.
Exclusion criteria
Exclusion criteria: Patients with contraindications to receive any of the medications (sodium warfarin or aspirin)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Absence of thrombosis inside of the extra-cardíac conduit, diagnosed by transesophageal echocardiography: analyzed by one examiner to assess the absence of thrombus imaging in light of extra-cardiac conduit. Absence of thrombosis inside of the extra-cardíac conduit diagnosed by CT angiography: acquisition with only carried out by one examiner with contrast, evaluating the absence of thrombus in the lumen or adhered to the wall of the extra-cardíac conduit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Absence of subclinical thromboembolism diagnosed by scintigraphy ventilation-perfusion, assessed by one examiner. The interpretation criteria follow the standardization scheme Nuclear Medicine Service of the Heart Hospital of Syrian Sanatorium Association, according to guidelines established by prospective investigation of pulmonary embolism diagnosis (PIOPED) | — |
Countries
Brazil
Contacts
Public ContactCristiane Pessotti
Hospital do Coração - Associação do Sanatório Sírio
Outcome results
None listed